Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-cash Items (2020 - 2025)

Journey Medical (DERM) has disclosed Non-cash Items for 6 consecutive years, with $5.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items fell 47.98% year-over-year to $5.5 million, compared with a TTM value of $5.5 million through Sep 2025, down 47.98%, and an annual FY2024 reading of $6.2 million, down 99.82% over the prior year.
  • Non-cash Items was $5.5 million for Q3 2025 at Journey Medical, down from $14.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $9.7 billion in Q4 2021 and bottomed at $1.6 million in Q1 2023.
  • Average Non-cash Items over 5 years is $906.9 million, with a median of $7.8 million recorded in 2021.
  • The sharpest move saw Non-cash Items surged 121667.12% in 2021, then tumbled 99.82% in 2024.
  • Year by year, Non-cash Items stood at $9.7 billion in 2021, then plummeted by 77.04% to $2.2 billion in 2022, then surged by 55.16% to $3.4 billion in 2023, then crashed by 99.82% to $6.2 million in 2024, then dropped by 10.61% to $5.5 million in 2025.
  • Business Quant data shows Non-cash Items for DERM at $5.5 million in Q3 2025, $14.7 million in Q2 2025, and $10.9 million in Q1 2025.